For the quarter ending 2025-09-30, CATX has $294,825K in assets. $52,609K in debts. $26,762K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 26,762 | 28,849 | ||
| Short-term investments | 147,375 | 162,729 | ||
| Accounts receivable, net of allowance for doubtful accounts 375 and 543 | 179 | 225 | ||
| Prepaid expenses and other current assets | 4,184 | 4,155 | ||
| Total current assets | 178,500 | 195,958 | ||
| Property and equipment, gross | 69,546 | - | ||
| Less accumulated depreciation | 5,195 | - | ||
| Property and equipment, net | 64,351 | 62,599 | ||
| Right-of-use asset, net | 1,536 | 1,767 | ||
| Restricted cash | - | 0 | ||
| Intangible assets, in-process research and development | 50,000 | 50,000 | ||
| Other assets, net | 438 | 401 | ||
| Total assets | 294,825 | 310,725 | ||
| Accounts payable and accrued expenses | 13,148 | 7,048 | ||
| Lease liability | 704 | 847 | ||
| Accrued personnel expenses | 6,711 | 5,037 | ||
| Note payable | 55 | 54 | ||
| Deferred income (note 3) | 0 | 0 | ||
| Total current liabilities | 20,618 | 12,986 | ||
| Lease liability, net of current portion | 971 | 1,071 | ||
| Note payable, net of current portion | 1,583 | 1,597 | ||
| Deferred income, net of current portion (note 3) | 26,600 | 26,600 | ||
| Deferred tax liability | 2,495 | 2,495 | ||
| Other noncurrent liabilities | 342 | 284 | ||
| Total liabilities | 52,609 | 45,033 | ||
| Common stock 0.001 par value authorized 750,000,000 shares issued 74,337,990 and 70,671,464 shares | 74 | 74 | ||
| Additional paid-in capital | 539,378 | 536,996 | ||
| Accumulated other comprehensive income (loss) | 114 | 3 | ||
| Accumulated deficit | -297,350 | -271,381 | ||
| Total stockholders' equity | 242,216 | 265,692 | ||
| Total liabilities and stockholders' equity | 294,825 | 310,725 | ||
Perspective Therapeutics, Inc. (CATX)
Perspective Therapeutics, Inc. (CATX)